标题
Discovery of farnesoid X receptor and its role in bile acid metabolism
作者
关键词
Bile acid receptors, FXR, Metabolic disease, Fatty liver diseases, Cholestasis
出版物
MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 548, Issue -, Pages 111618
出版商
Elsevier BV
发表日期
2022-03-11
DOI
10.1016/j.mce.2022.111618
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
- (2021) Lulu Sun et al. Nature Reviews Gastroenterology & Hepatology
- TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation
- (2021) Yong Shi et al. Frontiers in Immunology
- Hypothalamic bile acid-TGR5 signaling protects from obesity
- (2021) Ashley Castellanos-Jankiewicz et al. Cell Metabolism
- Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
- (2021) Maria Reich et al. JOURNAL OF HEPATOLOGY
- Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling
- (2021) Silvia Marchianò et al. FASEB JOURNAL
- Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
- (2021) Margaux Nawrot et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
- (2020) John Y. L. Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- FXR Agonists as Therapy for Liver Disease
- (2020) Jay H. Hoofnagle HEPATOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis
- (2020) Kristoffer Kjærgaard et al. JOURNAL OF HEPATOLOGY
- Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
- (2020) Snehal N. Chaudhari et al. Nature Chemical Biology
- Hepatic autophagy deficiency remodels gut microbiota for an adaptive protection via FGF15-FGFR4 signaling
- (2020) Shengmin Yan et al. Cellular and Molecular Gastroenterology and Hepatology
- Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
- (2020) Olivier Govaere et al. Science Translational Medicine
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- Hepatokines and adipokines in NASH-related hepatocellular carcinoma
- (2020) Ozlem Kucukoglu et al. JOURNAL OF HEPATOLOGY
- Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice
- (2019) Patricia D. Finn et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Deficiency of both farnesoid X receptor and Takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice
- (2019) Jessica M. Ferrell et al. HEPATOLOGY
- Gut microbial metabolites in obesity, NAFLD and T2DM
- (2019) Emanuel E. Canfora et al. Nature Reviews Endocrinology
- Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract
- (2019) Matthew H. Foley et al. PLoS Pathogens
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- Bile Acids as Metabolic Regulators and Nutrient Sensors
- (2019) John Y. L. Chiang et al. Annual Review of Nutrition
- Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols
- (2019) Genta Kakiyama et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH
- (2019) Adriana Carino et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Regulations of bile acid metabolism in mouse models with hydrophobic bile acid composition
- (2019) Akira Honda et al. JOURNAL OF LIPID RESEARCH
- Animal models to study bile acid metabolism
- (2018) Jianing Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Reciprocal interactions between bile acids and gut microbiota in human liver diseases
- (2018) Tadashi Ikegami et al. HEPATOLOGY RESEARCH
- Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
- (2018) Thomas Jensen et al. JOURNAL OF HEPATOLOGY
- Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation
- (2018) Shinobu Miyazaki-Anzai et al. JOURNAL OF LIPID RESEARCH
- Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial
- (2018) Reza Nemati et al. OBESITY SURGERY
- Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
- (2018) Sangwon Byun et al. Nature Communications
- Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery
- (2018) Nadejda Bozadjieva et al. DIABETES
- Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1
- (2018) Linbing Fan et al. BIOLOGICAL CHEMISTRY
- FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
- (2018) Elliot S. Friedman et al. GASTROENTEROLOGY
- Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
- (2018) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
- (2017) Oscar Chávez-Talavera et al. GASTROENTEROLOGY
- Hepatic bile acid uptake in humans and mice: Multiple pathways and expanding potential role for gut-liver signaling
- (2017) Paul A. Dawson HEPATOLOGY
- The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice
- (2017) Yongqing Wang et al. HEPATOLOGY
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism
- (2017) Preeti Pathak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial
- (2017) Hilde Risstad et al. Surgery for Obesity and Related Diseases
- Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice
- (2017) Matthew McMillin et al. Frontiers in Cellular Neuroscience
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
- (2016) Cen Xie et al. DIABETES
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice
- (2016) Lili Ding et al. HEPATOLOGY
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders
- (2016) Jessica M. Ferrell et al. JOURNAL OF LIPID RESEARCH
- Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans
- (2016) Shogo Takahashi et al. JOURNAL OF LIPID RESEARCH
- Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice
- (2016) J-Y Yang et al. Mucosal Immunology
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
- (2016) Natalia Gomez-Ospina et al. Nature Communications
- Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
- (2016) Limin Zhang et al. mSystems
- Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
- (2016) Marialena Mouzaki et al. PLoS One
- Detection of FGF15 in Plasma by Stable Isotope Standards and Capture by Anti-peptide Antibodies and Targeted Mass Spectrometry
- (2015) Takeshi Katafuchi et al. Cell Metabolism
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
- (2015) Maria Reich et al. GUT
- TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice
- (2015) Anne K McGavigan et al. GUT
- Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice
- (2015) Su-Yeon Lee et al. HEPATOLOGY
- Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression
- (2015) Masayuki Nagahashi et al. HEPATOLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Novel therapeutic targets in primary biliary cirrhosis
- (2015) Jessica K. Dyson et al. Nature Reviews Gastroenterology & Hepatology
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Cytoplasmic Tyrosine Phosphatase Shp2 Coordinates Hepatic Regulation of Bile Acid and FGF15/19 Signaling to Repress Bile Acid Synthesis
- (2014) Shuangwei Li et al. Cell Metabolism
- Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2
- (2014) Runping Liu et al. HEPATOLOGY
- TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation
- (2014) Alessia Perino et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
- (2014) Klemens Högenauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transcriptional regulation of autophagy by an FXR–CREB axis
- (2014) Sunmi Seok et al. NATURE
- Nutrient-sensing nuclear receptors coordinate autophagy
- (2014) Jae Man Lee et al. NATURE
- FXR is a molecular target for the effects of vertical sleeve gastrectomy
- (2014) Karen K. Ryan et al. NATURE
- GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells
- (2014) Guiyu Lou et al. PLoS One
- Bile Acid Receptor TGR5 Agonism Induces NO Production and Reduces Monocyte Adhesion in Vascular Endothelial Cells
- (2013) Taiki Kida et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Functions of autophagy in normal and diseased liver
- (2013) Mark J. Czaja et al. Autophagy
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Human Insulin Resistance Is Associated With Increased Plasma Levels of 12 -Hydroxylated Bile Acids
- (2013) R. A. Haeusler et al. DIABETES
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
- (2013) Noémie Péan et al. HEPATOLOGY
- TGR5 signalling inhibits the production of pro-inflammatory cytokines byin vitrodifferentiated inflammatory and intestinal macrophages in Crohn's disease
- (2013) Kazuaki Yoneno et al. IMMUNOLOGY
- Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
- (2013) Fei Li et al. Nature Communications
- The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control
- (2012) Dimitri J. Pournaras et al. ENDOCRINOLOGY
- Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
- (2012) M. J. Potthoff et al. GENES & DEVELOPMENT
- Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
- (2012) Bo Kong et al. HEPATOLOGY
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10 −/− mice
- (2012) Suzanne Devkota et al. NATURE
- Conjugated Bile Acids Associate with Altered Rates of Glucose and Lipid Oxidation after Roux-en-Y Gastric Bypass
- (2012) M. Simonen et al. OBESITY SURGERY
- Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action
- (2012) Raoul Poupon Clinics and Research in Hepatology and Gastroenterology
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
- (2011) K.B.M. Saiful Islam et al. GASTROENTEROLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes
- (2011) Elaine Studer et al. HEPATOLOGY
- The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract
- (2011) Serge J.L.B. Zweers et al. HEPATOLOGY
- Glucose and Insulin Induction of Bile Acid Synthesis
- (2011) Tiangang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ligand-Dependent Regulation of the Activity of the Orphan Nuclear Receptor, Small Heterodimer Partner (SHP), in the Repression of Bile Acid BiosyntheticCYP7A1andCYP8B1Genes
- (2011) Ji Miao et al. MOLECULAR ENDOCRINOLOGY
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- The bile acid sensor FXR regulates insulin transcription and secretion
- (2010) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance
- (2010) Ling Yang et al. Cell Metabolism
- Nuclear Receptor SHP, a Death Receptor That Targets Mitochondria, Induces Apoptosis and Inhibits Tumor Growth
- (2010) Y. Zhang et al. MOLECULAR AND CELLULAR BIOLOGY
- Pathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M. Brunt Nature Reviews Gastroenterology & Hepatology
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine
- (2009) Ann M. Thomas et al. HEPATOLOGY
- Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice
- (2009) Emina Halilbasic et al. HEPATOLOGY
- The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
- (2009) Verena Keitel et al. HEPATOLOGY
- Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
- (2009) Yanqiao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New molecular insights into the mechanisms of cholestasis
- (2009) Martin Wagner et al. JOURNAL OF HEPATOLOGY
- Bile acids: the role of peroxisomes
- (2009) Sacha Ferdinandusse et al. JOURNAL OF LIPID RESEARCH
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- Autophagy regulates lipid metabolism
- (2009) Rajat Singh et al. NATURE
- Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
- (2009) Stefano Fiorucci et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Expression and function of the bile acid receptor TGR5 in Kupffer cells
- (2008) Verena Keitel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms of Cholestasis
- (2008) Gernot Zollner et al. Clinics in Liver Disease
- Mechanisms of Hepatic Fibrogenesis
- (2008) Scott L. Friedman GASTROENTEROLOGY
- Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis
- (2008) Young Joo Park et al. HEPATOLOGY
- Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression
- (2008) Kwang-Hoon Song et al. HEPATOLOGY
- Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
- (2008) Kristiaan Wouters et al. HEPATOLOGY
- Fructose consumption as a risk factor for non-alcoholic fatty liver disease
- (2008) Xiaosen Ouyang et al. JOURNAL OF HEPATOLOGY
- Farnesoid X Receptor Protects Liver Cells from Apoptosis Induced by Serum Deprivationin Vitroand Fastingin Vivo
- (2008) Yan-Dong Wang et al. MOLECULAR ENDOCRINOLOGY
- Targeting bile-acid signalling for metabolic diseases
- (2008) Charles Thomas et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started